Leap Therapeutics Inc (NASDAQ:LPTX)
| 1.10 Delayed Data As of May 27 |  -0.10 / -8.33%Today’s Change | 0.92 Today|||52-Week Range 4.17 | -66.05% Year-to-Date |
Latest LPTX News | Press Releases
| Global Blood (GBT) Thrives on Oxbryta, Overdependence a Woe May 26 / Zacks.com - Paid Partner Content | Seagen (SGEN) Posts Positive Data from New Study on Tukysa May 24 / Zacks.com - Paid Partner Content |
| INmune Bio (INMB) Down on Clinical Hold for Alzheimer's Study May 25 / Zacks.com - Paid Partner Content | AbbVie (ABBV) Files NDA for Parkinson's Disease Candidate May 23 / Zacks.com - Paid Partner Content |
| SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal May 25 / Zacks.com - Paid Partner Content | Lilly's (LLY) Olumiant Gets CHMP Nod for Alopecia Areata May 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.20 |
| Today’s open | 1.13 |
| Day’s range | 0.95 - 1.13 |
| Volume | 216,689 |
| Average volume (3 months) | 1,126,415 |
| Market cap | $103.3M |
Data as of 3:59pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | +25.36% |
| Earnings growth (this year) | -339.89% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 185.38 |
| Price/Book | 0.96 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CSBRChampions Oncology I... | +0.04 | +0.55% |
| CRTXCortexyme Inc | -0.05 | -1.82% |
| LJPCLa Jolla Pharmaceuti... | -0.08 | -2.08% |
| AGLEAeglea Bio Therapeut... | +0.03 | +1.94% |
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | August 12, 2022 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$40.6M |
| Net profit margin | -2,705.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
